TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
EOSE

Eos Energy Enterprises Inc

Industrials · Electrical Equipment & Parts · listed since 2020

4.00$ +1.1% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Substance risk

We found at least one documented issue that threatens the company itself — regardless of how the stock is currently valued.

Why this colour

The light is red on substance, not on price: shareholders' deficit of −$868.4 million against $799.3 million of total assets (March 31, 2026), operating cash flow of −$211.2 million in 2025, cash plus all restricted cash down from $624.6 million to roughly $364 million in six months, and financing that hangs on a single counterparty whose preferred stock ranks ahead of every common share. Whoever holds today is betting on one number: that the $1.69 to $1.73 of cost per $1 of revenue keeps falling until it passes $1.00 — and that it gets there before the EBITDA and revenue covenants bite with the quarter ending March 31, 2027 and before the next financing round is needed. The curve has bent for four straight years, so that bet has a real basis. Whoever buys new pays roughly 11 to 17 times 2025 revenue for a business with negative gross margins, and buys behind a preferred stock that grows its claim precisely when the news is good — being right about the factory is not sufficient to be right about the stock. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Eos Energy is the rare case where the pictures do not lie and the arithmetic still does not work. The factory in Turtle Creek is real, the zinc chemistry is real, the DOE loan is the first of its kind — and in 2025 the production ramp finally arrived, revenue rising more than sevenfold to $114.2 million with the cost of $1 of revenue falling from $10.11 (2021) to $2.26. The going-concern doubt that defined this stock for years is formally gone. What has not been solved is the economics: cost of goods sold of $258.0 million against that revenue, an audited order book of $45.8 million, a shareholders' deficit of −$868.4 million (March 31, 2026), and a Series B Preferred held by Cerberus that ranks ahead of every common share, was carried at $1,361.5 million against $885.2 million of total assets, and cost common shareholders $770.7 million of remeasurement in one year. In July 2026 the company's own shareholders subscribed for only a quarter of the rights offered. Not investment advice.

Technology & market position

A genuine niche with policy tailwind: zinc-based Znyth systems with a water-based electrolyte — non-flammable, no lithium, cobalt or rare earths, primarily domestic raw materials — built for 3- to 12-hour storage. The annual report (10-K for 2025) describes the Z3 as the only U.S.-designed and manufactured module offering utilities an alternative to lithium-ion and lead-acid for that duration; the DOE facility is the first Title XVII battery loan ever closed.

Production ramp

The thing Eos had failed to prove for five years, it proved in 2025: revenue from $15.6 million (2024) to $114.2 million (+632 percent), $57.0 million in the first quarter of 2026 against $10.5 million a year earlier, and a preliminary $68 million to $69 million in the second quarter (8-K of July 15, 2026) — after revenue had gone sideways and then down from 2022 to 2024. Cost per $1 of revenue fell from $10.11 (2021) to $2.26 (2025), $1.78 in Q1 2026 and a preliminary $1.69 to $1.73 in Q2 2026.

Unit economics

Nothing is earned per battery. Cost of goods sold of $258.0 million against $114.2 million of revenue in 2025 (gross loss $143.8 million), and a further $44.4 million gross loss in the first quarter of 2026. Until the cost of $1 of revenue passes below $1.00, every additional order deepens the loss; the company itself declines to promise the crossing: "we may be unable to sustain or increase our profitability in the future" (10-K for 2025, Item 1A).

Capital structure & Cerberus

The Series B Preferred issued to Cerberus ranks ahead of every common share and is remeasured to its redemption value: $770.7 million charged against common shareholders in 2025 alone (2024: $278.3 million), turning the $969.6 million net loss into $1,744.8 million attributable to common (−$6.69 per share). The preferred was carried at $1,361.5 million on December 31, 2025 — against total assets of $885.2 million. 159,587,654 shares underlie the Cerberus securities, about 29 percent fully diluted.

Financing & liquidity

The going-concern doubt is formally lifted in the 10-K for 2025 after roughly $1 billion raised — a real change, and preliminary total cash of roughly $364 million (June 30, 2026) sits far above the $15.0 million minimum liquidity covenant. But shareholders' deficit stays at −$868.4 million against $799.3 million of total assets (March 31, 2026), the burn continues (operating cash flow −$211.2 million in 2025; cash plus all restricted cash down from $624.6 million to roughly $364 million in six months), the minimum EBITDA and revenue covenants first bite with the quarter ending March 31, 2027, and the July 2026 rights offering brought in $37.7 million instead of $150 million (8-K of July 23, 2026).

Valuation & signals

Between roughly $1.3 billion (fundamental data, July 27/28, 2026) and just over $1.9 billion (the documented $5.55 price of July 1, 2026 times about 353.2 million shares) sits a price-to-sales ratio of about 11 to 17 on 2025 revenue — a software-like multiple on a business with negative gross margins, with $582.7 million of preferred ranking ahead of the common. Analysts lean constructive (4 strong buy, 5 hold, target ~$9.11), but the scanner's structural readings stay red: equity ratio −35.8 percent, Altman Z-double-prime −3.95 (thresholds 1.1 / 2.6), stage 4, and 4 insider purchases against 16 sales (data as of July 8 and July 15, 2026).

Worth Noting

EOSE reached our research list via the Reddit hype scanner (ApeWisdom, 2 mentions in 24 hours, as of July 16, 2026) — the forums are barely watching this one. Scanner metrics carry the July 8, 2026 data cut-off and rotate daily.

A note on one figure you may see quoted differently elsewhere: some data providers report Eos's equity as about −$877 million for December 31, 2025. That nets the Series B Preferred into equity. The filing itself separates them: total shareholders' deficit of −$2,238.9 million, with $1,361.5 million of Series B Preferred shown above it as mezzanine (10-Q as of 03/31/2026, balance sheet). We follow the filing.

The reported bottom line is not a performance measure at this company: warrants and conversion rights are carried as liabilities and remeasured each period, so a rising share price produces losses and a falling one produces profits. Read gross profit and operating loss instead — and note that both critical audit matters in the 2025 audit concern exactly these instruments, not the manufacturing.

On valuation: the market value from fundamental data (roughly $1.3 billion, July 27/28, 2026) differs by more than a fifth from "documented filing price times documented share count" ($5.55 on July 1, 2026 times about 353.2 million shares = just over $1.9 billion). The reason is the share-price decline over those four weeks, not a data defect: the same data set carries a share price of $3.61 and a one-month performance of −40.7 percent. We therefore name both anchors with their dates and give the multiples as a range across those two dates instead of presenting either as the single right number. Analyses are evergreen, daily prices are not a buy argument.

Eos has announced full second-quarter 2026 results for August 5, 2026; the Q2 figures used here are the preliminary ones from the Form 8-K of July 15, 2026.

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at EOSE since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 3.00 $ to 19.20 $ · Last price: 4.00 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 1.5$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 364m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 98.1%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 2.8

Performance

Perf. 1M ?Price performance over the last month. -32.30%
Perf. 3M ?Price performance over the last 3 months. 25.30%
Perf. 6M ?Price performance over the last 6 months. -49.30%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). -43.40%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -69.3%
Perf. 1Y ?Price performance over the last 12 months. -53.18%
Perf. 3Y ?Price performance over the last 3 years. 53.67%
Perf. 5Y ?Price performance over the last 5 years. -69.55%
Perf. Since Inception ?Price performance since the first available trading day (06/03/2020) — with a complete history, that is since the IPO. -58.97%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 3.80$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 3.80$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 8.00$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 52.2
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 97.4%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 120.6%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 0.0
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey.
P/B ?Price-to-book ratio: market value relative to book equity.
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 7.2
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. -2.0
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up.

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. -84.8%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. -139.1%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. -246.8%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? -2,816.1%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). -30.0%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. very low -35.8%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. warning zone -3.95
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 6 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 631.79%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 98.68%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. -104.10%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 4
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 36
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 42
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. C (49 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Electrical Equipment & Parts

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Eos Energy Enterprises Inc EOSE 1.5 -2.0 -84.8 -139.1 631.8 -53.2
Vertiv Holdings Co VRT 104.3 55.5 38.8 38.0 16.4 27.7 76.7
Bloom Energy Corp BE 79.9 232.5 31.7 9.6 37.3 252.4
nVent Electric PLC NVT 24.5 48.7 23.6 36.4 16.0 29.5 54.5
Hubbell Inc HUBB 23.7 26.3 19.4 35.3 17.8 3.8 2.1
Forgent Power Solutions, Inc. FPS 11.6 1,906.0 68.3 34.3 10.4 315.4
Advanced Energy Industries Inc AEIS 10.8 50.1 31.6 40.0 14.3 21.4 61.5
Acuity Brands Inc AYI 9.1 20.1 11.7 48.7 16.1 13.1 -11.6
Enersys ENS 6.7 22.6 11.4 29.8 13.4 3.7 63.7
Median of companies shown 11.6 48.7 23.6 35.3 14.3 27.7 58.0

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2018 · Operating income: -33 $M 2018 · Net income: -29 $M 2019 · Revenue: 1 $M 2019 · Operating income: -27 $M 2019 · Net income: -79 $M 2020 · Revenue: 0 $M 2020 · Operating income: -39 $M 2020 · Net income: -67 $M 2021 · Revenue: 5 $M 2021 · Operating income: -135 $M 2021 · Net income: -124 $M 2022 · Revenue: 18 $M 2022 · Operating income: -221 $M 2022 · Net income: -230 $M 2023 · Revenue: 16 $M 2023 · Operating income: -153 $M 2023 · Net income: -230 $M 2024 · Revenue: 16 $M 2024 · Operating income: -175 $M 2024 · Net income: -686 $M 2025 · Revenue: 114 $M 2025 · Operating income: -257 $M 2025 · Net income: -970 $M
20182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2018 -33 -29 -25 1 15
2019 1 -27 -79 -1.35 -24 -74 13
2020 0 -39 -67 -1.37 -27 121 138
2021 5 -135 -124 -2.36 -116 32 169
2022 18 -221 -230 -3.68 -197 -133 107
2023 16 -153 -230 -1.81 -145 -111 186
2024 16 -175 -686 -3.23 -154 -1,070 260
2025 114 -257 -970 -3.72 -211 -877 885

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 7.3 $M Q4 2025: Q1 · 10.5 $M Q1 2025: Q2 · 15.2 $M Q2 2025: Q3 · 30.5 $M Q3 2025: Q4 · 58.0 $M Q4 2026: Q1 · 57.0 $M Q1 2026: Q2 · 68.8 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -1.24 7 9.70 -3,696.70 -43 -56
2025: Q1 0.03 11 58.40 144.70 -29 -34
2025: Q2 -0.94 15 1,596.70 -1,463.20 -66 -73
2025: Q3 -2.36 31 3,472.80 -2,102.10 -66 -83
2025: Q4 -0.46 58 699.60 -207.70 -50 -75
2026: Q1 0.93 2,592.80 57 444.70 893.40 -120 -155
2026: Q2 -1.20 -27.70 69 352.60 -400.70 -72 -107

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 4 of our scanner strategies — each hit links to the scanner.

Growth

Research

Risk & Weakness

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 9
Price Target (average) 6.61$
Distance to price 65.3% The price target sits 65.3% above the current price.

Distribution of Recommendations

Strong Buy 4
Buy 0
Hold 5
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 -0.09 -1.41 – 0.89 307 97.8% 5
12/31/2027 -0.17 -0.21 – -0.07 576 -96.5% 5

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Neutral

Geprüft am 16.07.2026 gegen die Geschäftsberichte (10-K) 2025 (eingereicht 26.02.2026) und 2024 (04.03.2025) sowie die vier jüngsten Quartalsberichte (10-Q) bis 31.03.2026: Eos Energy verdient sein Geld ausschließlich mit zinkbasierten Batteriespeichersystemen (Znyth/Z3) fürs Stromnetz — 2025 entfielen 112,0 von 114,2 Mio. $ Umsatz auf Produktverkäufe, kein Cent auf KI-Produkte oder -Dienste. KI kommt in den Filings in drei Rollen vor, von denen keine den Kriterienkatalog erfüllt: (1) als Nachfragetreiber im Endmarkt — der 10-K 2025 nennt „incremental load growth associated with the expansion of artificial intelligence (“AI”), high-performance computing (“HPC”) and data center infrastructure“ als Grund für steigenden Speicherbedarf, und Kooperationen mit Talen Energy (10/2025) sowie TURBINE-X Energy (04/2026) zielen auf Stromversorgung für KI-Rechenzentren; das ist ein KI-nahes Endmarkt-Narrativ, kein Verkauf eigener KI-Produkte (Endmarkt-Exponierung allein begründet kein „verkauft“). (2) als generische Risiko-Floskel im Item 1A des 10-K 2025 („As with many new and emerging technologies, AI presents numerous risks and challenges that could adversely affect our business“) ohne konkreten Bezug aufs eigene Geschäftsmodell — nach Vorrang-Regel 3 kein „bedroht“-Beleg. (3) als hypothetische Cybersecurity-Erwähnung; der 10-K 2024 enthält überhaupt nur eine einzige KI-Nennung dieser Art. Operativer KI-Einsatz ist in keinem der ausgewerteten Filings belegt — damit kein „nutzt“. Ergebnis: neutral (dokumentierter Negativ-Befund).

View the full file — quotes, sources, reviewed filings

Filings Reviewed: 10-Q 2026-05-13 · 10-K 2026-02-26 · 10-Q 2025-11-05 · 10-Q 2025-07-30 · 10-Q 2025-05-06 · 10-K 2025-03-04

Rated on July 16, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

4 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years 85.4%
  • More than 10% revenue growth is expected for the coming year 98.7%
  • Share count grows by less than 3% a year 61.0%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 399.8%
  • Gross margin at 40% or higher and without meaningful erosion -126.0%
  • Goodwill from acquisitions does not grow faster than revenue 0.5%
  • Net debt below twice EBITDA failed
  • Operating cash flow covers the profits of the last three years 1,375 m
  • Return on capital at 15% or higher, or up versus two years ago -34.7%
  • Insiders hold at least 10% or are net buyers 1.3%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

4/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 147.2%
  • Exp. sales growth 3Y > 5% 124.6%
  • EBIT growth 10Y > 5%
  • Exp. EBIT growth 3Y > 5% 124.6%
  • Net debt < 4x EBIT
  • EBIT positive, 10Y straight 0
  • Max. EBIT decline < 50%
  • Return on equity > 15%
  • ROCE > 15% -34.7%
  • Expected return > 10% 85.8%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Sep 16, 2026 Puri Sumeet Chief Accounting Officer Sell 43,750 3.92 171,500
Sep 16, 2026 Mastrangelo Joe Chief Executive Officer Sell 250,000 3.92 980,000
Sep 14, 2026 Puri Sumeet Chief Accounting Officer Other 87,500 0.00
Sep 14, 2026 Mastrangelo Joe Chief Executive Officer Other 500,000 0.00
Sep 14, 2026 Song Haiyan Director Buy 5,000 3.84 19,200
Sep 11, 2026 Song Haiyan Director Buy 10,000 3.95 39,500
Sep 9, 2026 Puri Sumeet Chief Accounting Officer Sell 34,167 4.13 141,110
Sep 5, 2026 Puri Sumeet Chief Accounting Officer Other 68,333 0.00
Jul 28, 2026 Puri Sumeet Chief Accounting Officer Sell 29,167 3.36 98,001
Jul 28, 2026 Kroeker Nathan Chief Commercial Officer Sell 110,417 3.36 371,001

View all insider transactions →

The company

About the Company

Eos Energy Enterprises, Inc. entwirft, entwickelt, fertigt und vermarktet Energiespeicherlösungen für Anwendungen im Versorgungsmaßstab, Microgrids sowie Gewerbe und Industrie in den USA.

Employees
787
Headquarters
Pittsburgh, PA
Address
Two Allegheny Center, 15212 Pittsburgh, United States
Phone
732 225 8400
Website
eose.com
IPO Date
06/03/2020
ISIN
US29415C1018

Management

Management
Name Title Birth Year
Joseph R. Mastrangelo Jr. CEO & Director 1969
Nathan G. Kroeker C.P.A. Executive Officer 1974
Michelle Buczkowski Chief Commercial Officer 1985
Alessandro Lagi Chief Financial Officer
John Mahaz Chief Operating Officer 1988
Sumeet Puri Chief Accounting Officer 1974
Francis Richey Chief Technology Officer
Elizabeth Higley Director of Investor Relations
Marie Batz Martin Chief Legal Officer
Erik Todd Executive Vice President of Sales

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 09/14/2026 Eos Energy Enterprises, Inc. (EOSE): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 08/25/2026 Eos Energy Enterprises, Inc. (EOSE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 08/06/2026 Eos Energy Enterprises, Inc. (EOSE): Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Statements and Exhibits SEC ↗
  • 08/05/2026 Eos Energy Enterprises, Inc. (EOSE): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
  • 07/23/2026 Eos Energy Enterprises, Inc. (EOSE): Other Events; Financial Statements and Exhibits SEC ↗
  • 07/15/2026 Eos Energy Enterprises, Inc. (EOSE): Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits SEC ↗
  • 07/09/2026 Eos Energy Enterprises, Inc. (EOSE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?